109
Views
0
CrossRef citations to date
0
Altmetric
Research Articles

Potential utility of B-type natriuretic peptides in secondary prevention following percutaneous coronary intervention in remote communities of Western Australia

, , , , &
Pages 458-465 | Received 12 Aug 2022, Accepted 17 Apr 2023, Published online: 11 May 2023

References

  • Alston, L., et al., 2019. Policy makers’ perceptions of the high burden of heart disease in rural Australia: Implications for the implementation of evidence-based rural health policy. PLoS one, 14 (4), e0215358.
  • Arnold, R.H., et al., 2020. Rural and remote cardiology during the COVID-19 pandemic: Cardiac Society of Australia and New Zealand (CSANZ) consensus statement. Heart, lung & circulation, 29 (7), e88–e93.
  • Australian Institute of Health and Welfare, 2023. Heart, stroke and vascular disease: Australian facts. AIHW, Australian Government. https://www.aihw.gov.au/reports/heart-stroke-vascular-diseases/hsvd-facts/contents/heart-stroke-and-vascular-disease-subtypes/coronary-heart-disease
  • Beller, G.A., 2011. Maximizing the clinical value of stress myocardial perfusion imaging. Journal of nuclear cardiology: official publication of the American society of nuclear cardiology, 18 (1), 1–2.
  • Brieger, D.B., and Redfern, J., 2013. Contemporary themes in acute coronary syndrome management: from acute illness to secondary prevention. The medical journal of Australia, 199 (3), 174–178.
  • Brown, A., 2009. Bridging the survival gap between Indigenous and non-Indigenous Australians: priorities for the road ahead. Heart, lung & circulation, 18 (2), 96–100.
  • Caruso, D., et al., 2016. Dynamic CT myocardial perfusion imaging. European journal of radiology, 85 (10), 1893–1899.
  • Durey, A., et al., 2008. Overseas-trained doctors in Indigenous rural health services: negotiating professional relationships across cultural domains. Australian and New Zealand journal of public health, 32 (6), 512–518.
  • Fihn, S. D., et al., 2012. ACCF/AHA/ACP/AATS/PCNA/SCAI/STS guideline for the diagnosis and management of patients with stable ischemic heart disease. Circulation, 126, e357–e471.
  • Galassi, A.R., et al., 2006. Usefulness of exercise myocardial scintigraphy in multivessel coronary disease after incomplete revascularization with coronary stenting. The American journal of cardiology, 97 (2), 207–215.
  • Giedd, K.N., and Bergmann, S.R., 2004. Myocardial perfusion imaging following percutaneous coronary intervention: the importance of restenosis, disease progression, and directed reintervention. Journal of the American college of cardiology, 43 (3), 328–336.
  • Goyder, C.R., et al., 2023. Diagnostic accuracy of natriuretic peptide screening for left ventricular systolic dysfunction in the community: systematic review and meta‐analysis. ESC heart failure. https://doi.org/10.1002/ehf2.14314. Epub ahead of print. PMID: 36785511.
  • Hamilton, S., et al., 2018. Evidence to service gap: cardiac rehabilitation and secondary prevention in rural and remote Western Australia. BMC health services research, 18 (1), 64.
  • Harb, S.C., and Marwick, T.H., 2014. Prognostic value of stress imaging after revascularization: a systematic review of stress echocardiography and stress nuclear imaging. American heart journal, 167 (1), 77–85.
  • Health A.I.o. and Welfare, 2020. Cardiovascular disease. Canberra: AIHW.
  • Hendel, R.C., et al., 2009. ACCF/ASNC/ACR/AHA/ASE/SCCT/SCMR/SNM 2009 appropriate use criteria for cardiac radionuclide imaging: a report of the American College of Cardiology Foundation Appropriate Use Criteria Task Force, the American Society of Nuclear Cardiology, the American College of Radiology, the American Heart Association, the American Society of Echocardiography, the Society of Cardiovascular Computed Tomography, the Society for Cardiovascular Magnetic Resonance, and the Society of Nuclear Medicine. Circulation, 119 (22), e561–e587.
  • Itakura, R., et al., 2020. A highly-sensitized response of B-type natriuretic peptide to cardiac ischaemia quantified by intracoronary pressure measurements. Scientific reports, 10 (1), 2403.
  • Kamien, M., 2009. Evidence-based policy versus evidence-based rural health care reality checks. Australian journal of rural health, 17, 65–67.
  • Katzenellenbogen, J., et al., 2015. Information for action: improving the heart health story for Aboriginal people in WA. Perth, Australia: University of Western Australia, Western Australian Centre for Rural Health.
  • Koh, A.S., et al., 2017. Long-term prognostic value of appropriate myocardial perfusion imaging. The American journal of cardiology, 119 (12), 1957–1962.
  • Kotecha, D., et al., 2019. B-type natriuretic peptide trumps other prognostic markers in patients assessed for coronary disease. BMC medicine, 17 (1), 11.
  • Lee, J.-W., et al., 2019. Prognostic value of short-term follow-up B-type natriuretic peptide levels after hospital discharge in patients with acute myocardial infarction. International journal of cardiology, 289, 19–23.
  • Matsuo, S., et al., 2008. Prognostic value of normal stress myocardial perfusion imaging in Japanese population. Circulation journal: official journal of the japanese circulation society, 72 (4), 611–617.
  • Randall, S.M., et al., 2016. Western Australia population trends in the incidence of acute myocardial infarction between 1993 and 2012. International journal of cardiology, 222, 678–682.
  • Redfern, J., and Chow, C.K., 2013. Secondary prevention of coronary heart disease in Australia: a blueprint for reform. Medical journal of Australia, 198, 70–71.
  • Redfern, J., et al., 2020. Cardiac rehabilitation and secondary prevention roundtable: Australian implementation and research priorities. Heart, lung & circulation, 29 (3), 319–323.
  • Richards, A.M., 2018. N-terminal B-type natriuretic peptide in heart failure. Heart failure clinics, 14 (1), 27–39.
  • Roth, C., et al., 2019. High N-terminal proB-type natriuretic peptide indicates elevated risk of death after percutaneous coronary intervention compared to coronary artery bypass surgery in patients with left ventricular dysfunction. Journal of clinical medicine, 8 (6), 898.
  • Scholte, A.J.H.A., 2011. Cardiac risk assessment in asymptomatic diabetes: Combing different imaging modalities and surrogate markers? Journal of nuclear cardiology: official publication of the American society of nuclear cardiology, 18 (3), 393–395.
  • Singh, T.P., et al., 2018. Presentation and outcomes of indigenous Australians with peripheral artery disease. BMC cardiovascular disorders, 18 (1), 1–7.
  • Sterling, M.R., et al., 2018. N-terminal pro-B-type natriuretic peptide and microsize myocardial infarction risk in the reasons for geographic and racial differences in stroke study. BMC cardiovascular disorders, 18 (1), 66.
  • Tan, E.J., et al., 2021. Trends in ischaemic heart disease in Australia, 2001–2015: A comparison of urban and rural populations. Heart, lung & circulation, 30 (7), 971–977.
  • Teng, T.K., et al., 2018. Patterns of Medicare-funded primary health and specialist consultations in Aboriginal and non-Aboriginal Australians in the two years before hospitalisation for ischaemic heart disease. International journal for equity in health, 17 (1), 111.
  • Tweet, M.S., et al., 2015. Stress echocardiography: What is new and how does it compare with myocardial perfusion imaging and other modalities? Current cardiology reports, 17 (6), 43.
  • Wiemers, P.D., et al., 2018. An overview of indigenous Australian disadvantage in terms of ischaemic heart disease. Heart, lung & circulation, 27 (11), 1274–1284.
  • Wiersma, J.J., et al., 2010. NT-pro-BNP is associated with inducible myocardial ischemia in mildly symptomatic type 2 diabetic patients. International journal of cardiology, 145 (2), 295–296.
  • Wong, Y.-K., et al., 2019. High-sensitivity troponin I and B-type natriuretic peptide biomarkers for prediction of cardiovascular events in patients with coronary artery disease with and without diabetes mellitus. Cardiovascular diabetology, 18 (1), 12.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.